The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
1. Current Status, Position
Reinier van Hest is a hospital pharmacist at the Amsterdam UMC, where his main expertise is in infectious diseases and antimicrobial agents with a focus on antimicrobial stewardship, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring. He is also responsible for the hospital pharmacy residency programme.
2. Education
He studied pharmacy at the University of Utrecht and became a licensed pharmacist in 2003. He obtained a PhD at the Erasmus University Rotterdam in 2007 on the clinical pharmacokinetics of mycophenolate mofetil, and subsequently did the hospital pharmacy residency at the Erasmus MC Rotterdam. He became a licensed hospital pharmacist in 2009.
3. Research Area
His research focuses on several aspects of antimicrobial stewardship, and the pharmacokinetics and pharmacodynamics of antibiotics in different adult patient populations and infectious diseases. He is co-Chair of the antimicrobial stewardship team of the Amsterdam UMC and is a member of the Antimicrobial Stewardship Committee of the Dutch Working Party on Antibiotic Policy (SWAB). He is the co-Coordinator of the Antimicrobial Stewardship Monitor of the SWAB, which aims to create a national overview of the quality of the use of antimicrobial agents in hospitals and to provide participating hospitals with benchmark information on the quality of their antimicrobial use.
4. Conflict of interest
None